[PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C]. [electronic resource]
Producer: 20160831Description: 224-30 p. digitalISSN:- 0023-2149
- Adult
- Antiviral Agents -- therapeutic use
- Blood Group Antigens -- analysis
- Drug Therapy, Combination -- methods
- Female
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Interferon-alpha -- therapeutic use
- Interferons
- Interleukins -- genetics
- Liver Cirrhosis -- etiology
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Genetic
- Predictive Value of Tests
- Prognosis
- Recombinant Proteins -- therapeutic use
- Reproducibility of Results
- Ribavirin -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.